In partnership with

Cut Lead Review From Hours To Minutes

Sign up for a free trial of Attio, the agentic CRM.

Ask Attio to build a daily workflow that surfaces the deals that need your attention today, like anything with a stage change, a recent reply, or a new signal in the last 24 hours.

Review your pipeline in Claude, synced live from Attio via MCP.

That's it.

Try Attio Now

⚡ 5 THINGS TO KNOW RIGHT NOW — BEFORE THE BELL

1. 🏛️ Trump Declares "Operation Economic Fury" MAJOR Escalation — President Trump announced the "most crushing economic operation ever taken against any country" against Iran late Wednesday, threatening any nation that helps Tehran with "TREMENDOUS" consequences. Oil, defense, and Trump-trade names are the direct beneficiaries.

Upgrade now to get ALL 5 things to know!!!!

🌍 MACRO BACKDROP — THE BIG PICTURE

This is a HEADLINE-DEPENDENT session, full stop. Wednesday's close was constructive — the SPY finished at $769.06 (+0.21%), the DIA gained 0.26% to $534.27, while the QQQ slipped 0.20% to $716.08 as mega-cap tech took a breather. Under the surface, the real story was a full-blown risk dispersion trade: capital rotated hard into crypto, gold, and energy while chasing the biggest biotech pop of the year in Moderna.

The overnight narrative is dominated by a one-two macro punch: Trump's Wednesday-night declaration of "Operation Economic Fury" against Iran, and the Treasury's decision to double its long-bond buyback operations from $2B to $4B, which crushed the 30-year yield and triggered a broad rally in scarce, rate-sensitive assets — Bitcoin, gold, and growth equities alike. That combination is why you're seeing crypto up double digits and gold at a two-month high on the same morning geopolitical tension is escalating — a classic "flight to alternative stores of value" signal our community should be watching closely.

Thursday's session also carries a heavy earnings and data load: Walmart, Alibaba, Deere, NetEase, and Ross Stores all report, alongside weekly jobless claims, the Philly Fed survey, and July Leading Indicators. Polymarket currently prices a 66% chance of a higher S&P open for today's session — bullish positioning heading into the bell, but this is a market that can turn on a single Iran or North Korea headline. Trade the levels, not your bias — this tape can gap in either direction on a headline.

🗓️ TODAY'S ECONOMIC CALENDAR

🏦 SECTOR PERFORMANCE SNAPSHOT

🟢 ADVANCING

🤖 STOCK MARKET NEWS — SECTOR BY SECTOR

🔥 HOT SECTOR #1: 💊 BIOTECH / PHARMA

Moderna's Cancer Vaccine Moonshot

The single biggest story of the week is Moderna's Phase 3 INTerpath-001 melanoma trial, run in partnership with Merck, which met its endpoints and sent shares up over 100% intraday at the peak — one of the largest single-session biotech moves of 2026. Multiple sell-side desks scrambled to reprice the stock, with Morgan Stanley lifting its target to $89 from $39 and Goldman Sachs to $120 from $67, while William Blair upgraded to Outperform. Pre-market shows MRNA cooling off to $155.26 (-11.26%) from the parabolic highs — a natural give-back after a historic move, not a reversal of the underlying catalyst.

🎯 MRNA Trade Setup:

Upgrade now to receive full MRNA trade setup!!!!!!

⚠️ DISCLAIMER: This newsletter is for educational and informational purposes only. All trade ideas and analysis are based on publicly available information as of August 20, 2026. This is NOT financial advice. All trading involves substantial risk of loss. Always do your own due diligence and trade with proper risk management. DCG Command Center does not guarantee any trading results.

Subscribe to our premium content to read the full report.